Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Bone health in symptomatic carriers of haemophilia A: a protocol for a multicentre prospective matched-cohort study.

Tang GH, Norris E, Petrucci J, James PD, Lee A, Poon MC, Floros G, Boma-Fischer L, Teitel J, Nisenbaum R, Sholzberg M.

BMJ Open. 2019 Dec 2;9(12):e032891. doi: 10.1136/bmjopen-2019-032891.

2.

The safety and efficacy of ferumoxytol in the treatment of iron deficiency: a systematic review and meta-analysis.

Abdulrehman J, Tang GH, Auerbach M, Santesso N, Sholzberg M.

Transfusion. 2019 Dec;59(12):3646-3656. doi: 10.1111/trf.15587. Epub 2019 Nov 25.

PMID:
31762068
3.

The experience of postpartum bleeding in women with inherited bleeding disorders.

VanderMeulen H, Petrucci J, Floros G, Meffe F, Dainty KN, Sholzberg M.

Res Pract Thromb Haemost. 2019 Jul 26;3(4):733-740. doi: 10.1002/rth2.12246. eCollection 2019 Oct.

4.

A regional massive hemorrhage protocol developed through a modified Delphi technique.

Callum JL, Yeh CH, Petrosoniak A, McVey MJ, Cope S, Thompson T, Chin V, Karkouti K, Nathens AB, Murto K, Beno S, Pendergrast J, McDonald A, MacDonald R, Adhikari NKJ, Alam A, Arnold D, Barratt L, Beckett A, Brenneman S, Chaudhry HR, Collins A, Harvey M, Lampron J, Margarido C, McFarlan A, Nascimento B, Owens W, Pai M, Rizoli S, Ruijs T, Skeate R, Skelton T, Sholzberg M, Syer K, Viveiros JL, Theriault J, Tinmouth A, Van Heest R, White S, Zeller M, Pavenski K.

CMAJ Open. 2019 Sep 3;7(3):E546-E561. doi: 10.9778/cmajo.20190042. Print 2019 Jul-Sep.

5.

Development and implementation of a quality improvement toolkit, iron deficiency in pregnancy with maternal iron optimization (IRON MOM): A before-and-after study.

Abdulrehman J, Lausman A, Tang GH, Nisenbaum R, Petrucci J, Pavenski K, Hicks LK, Sholzberg M.

PLoS Med. 2019 Aug 20;16(8):e1002867. doi: 10.1371/journal.pmed.1002867. eCollection 2019 Aug.

6.

Delphi Approach for the Design of an Intraoperative Blood Conservation Pathway for Open Myomectomy.

Bao J, Shore EM, Simpson AN, Hare GMT, Sholzberg M, Robertson D.

J Obstet Gynaecol Can. 2019 Jul 8. pii: S1701-2163(19)30531-6. doi: 10.1016/j.jogc.2019.04.023. [Epub ahead of print]

PMID:
31296447
7.

Appropriateness of intravenous immunoglobulin use in immune thrombocytopenia (ITP): A Canadian centre deep dive audit.

Liu J, Pavenski K, Sholzberg M.

Transfus Apher Sci. 2019 Aug;58(4):491-494. doi: 10.1016/j.transci.2019.05.003. Epub 2019 May 10.

PMID:
31105060
8.

Intravenous iron versus oral iron or observation for gastrointestinal malignancies: a systematic review.

Tang GH, Dhir V, Scheer AS, Tricco AC, Sholzberg M, Brezden-Masley C.

Eur J Gastroenterol Hepatol. 2019 Jul;31(7):799-808. doi: 10.1097/MEG.0000000000001433.

PMID:
31082997
9.

Acquired haemophilia A and concomitant factor XIII consumption.

Abdulrehman J, Houston BL, Chaudhry H, Rivard GE, Teitel JM, Sholzberg M.

Haemophilia. 2019 May;25(3):e180-e183. doi: 10.1111/hae.13690. Epub 2019 Mar 7. No abstract available.

PMID:
30843631
10.

Response: patient blood management strategies for iron-deficiency anemia management in gastric cancer.

Tang GH, Sholzberg M, Brezden-Masley C.

Eur J Gastroenterol Hepatol. 2019 Mar;31(3):403. doi: 10.1097/MEG.0000000000001313. No abstract available.

PMID:
30720606
11.

Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale.

Arnold DM, Jamula E, Heddle NM, Cook RJ, Hsia C, Sholzberg M, Lin Y, Kassis J, Blostein M, Larratt L, Amini S, Schipperus M, Carruthers J, Lane SJ, Li N, Kelton JG.

Thromb Haemost. 2019 Mar;119(3):500-507. doi: 10.1055/s-0038-1677531. Epub 2019 Jan 27.

PMID:
30685874
12.

Malignant benign hematology.

Sholzberg M.

Res Pract Thromb Haemost. 2018 Dec 12;3(1):15-17. doi: 10.1002/rth2.12170. eCollection 2019 Jan.

13.

Exploring the effect of factor Xa inhibitors on rotational thromboelastometry: a case series of bleeding patients.

Mahamad S, Chaudhry H, Nisenbaum R, McFarlan A, Rizoli S, Ackery A, Sholzberg M.

J Thromb Thrombolysis. 2019 Feb;47(2):272-279. doi: 10.1007/s11239-018-1785-0.

PMID:
30506352
14.

Gaucher disease screening at a general adult hematology tertiary care centre: A prospective study.

Russell SA, Sholzberg M, Mangel J, Keeney M, Hedley B, Bode M, Gob A, Lam S, Phua C, Hsia CC.

Int J Lab Hematol. 2019 Jun;41(3):e66-e69. doi: 10.1111/ijlh.12960. Epub 2018 Dec 4. No abstract available.

PMID:
30512241
15.

Iron deficiency and anemia in patients with inherited bleeding disorders.

VanderMeulen H, Sholzberg M.

Transfus Apher Sci. 2018 Dec;57(6):735-738. doi: 10.1016/j.transci.2018.10.015. Epub 2018 Nov 17. Review.

PMID:
30470664
16.

Acquired factor XIII deficiency: A review.

Yan MTS, Rydz N, Goodyear D, Sholzberg M.

Transfus Apher Sci. 2018 Dec;57(6):724-730. doi: 10.1016/j.transci.2018.10.013. Epub 2018 Oct 30. Review.

PMID:
30446212
17.

Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy.

Sholzberg M, Xu Y.

JAMA. 2018 Oct 9;320(14):1485-1486. doi: 10.1001/jama.2018.13998. No abstract available.

PMID:
30242329
18.

Iron deficiency anemia in gastric cancer: a Canadian retrospective review.

Tang GH, Hart R, Sholzberg M, Brezden-Masley C.

Eur J Gastroenterol Hepatol. 2018 Dec;30(12):1497-1501. doi: 10.1097/MEG.0000000000001251.

PMID:
30179903
19.

Tackling overutilization of hospital tests and treatments: Lessons learned from a grassroots approach.

Hicks LK, O'Brien P, Sholzberg M, Veloce N, Trafford A, Sinclair D.

Healthc Manage Forum. 2018 Sep;31(5):186-190. doi: 10.1177/0840470418781172. Epub 2018 Aug 22.

PMID:
30133329
20.

Retrospective review of Acquired Haemophilia A from the largest Canadian Haemophilia treatment centre.

Jayakar JP, O'Neill N, Yan M, Nisenbaum R, Garvey MB, Teitel J, Sholzberg M.

Haemophilia. 2018 Sep;24(5):e383-e387. doi: 10.1111/hae.13598. Epub 2018 Aug 16. No abstract available.

PMID:
30112783
21.

Novel assays in the coagulation laboratory: a clinical and laboratory perspective.

Teichman J, Chaudhry HR, Sholzberg M.

Transfus Apher Sci. 2018 Aug;57(4):480-484. doi: 10.1016/j.transci.2018.07.008. Epub 2018 Jul 20. Review.

PMID:
30093248
22.

Haemophilia commentary: The utility of BATs.

Sholzberg M.

Haemophilia. 2018 Jul;24(4):522-524. doi: 10.1111/hae.13487. Epub 2018 Apr 17. No abstract available.

PMID:
29665138
23.

The authors respond to "Is referral necessary for abnormal bleeding?"

Sholzberg M, Teitel J, Hicks LK.

CMAJ. 2017 Nov 6;189(44):E1369. doi: 10.1503/cmaj.733365. No abstract available.

24.

A sticky situation: myocardial infarction in a young woman with immune thrombocytopenia on eltrombopag and a history of mediastinal radiation.

Teichman J, Taher A, Hashi A, Bagai A, Sholzberg M.

J Thromb Thrombolysis. 2018 Jan;45(1):192-195. doi: 10.1007/s11239-017-1577-y.

PMID:
29101508
25.

The Anticoagulated trauma patient in the age of the direct oral anticoagulants: a Canadian perspective.

Wood B, Nascimento B, Rizoli S, Sholzberg M, McFarlan A, Phillips A, Ackery AD.

Scand J Trauma Resusc Emerg Med. 2017 Aug 2;25(1):76. doi: 10.1186/s13049-017-0420-y.

26.

A 24-year-old woman with heavy menstrual bleeding.

Sholzberg M, Teitel J, Hicks LK.

CMAJ. 2017 Jun 5;189(22):E779-E780. doi: 10.1503/cmaj.161469. No abstract available.

27.

REDucing Unnecessary Coagulation Testing in the Emergency Department (REDUCED).

Fralick M, Hicks LK, Chaudhry H, Goldberg N, Ackery A, Nisenbaum R, Sholzberg M.

BMJ Qual Improv Rep. 2017 May 2;6(1). pii: u221651.w8161. doi: 10.1136/bmjquality.u221651.w8161. eCollection 2017.

28.

Coagulation Testing in a Bleeding Patient.

Fralick M, Sholzberg M.

JAMA. 2017 Apr 11;317(14):1478-1479. doi: 10.1001/jama.2017.2416. No abstract available.

PMID:
28399241
29.

Effect of moderate intensity exercise on haemostatic capacity in adults with haemophilia A and B: pilot study.

Sholzberg M, Floros G, Schneiderman JE, Kahr WH, Rand M, Pluthero F, Hossain T, Mahamad S, Nisenbaum R, Zhang C, O'Neill NE, Teitel J, Carcao M.

Haemophilia. 2017 Mar;23(2):e162-e165. doi: 10.1111/hae.13181. Epub 2017 Jan 22. No abstract available.

PMID:
28111839
30.

Recombinant porcine sequence factor VIII (rpFVIII) for acquired haemophilia A: practical clinical experience of its use in seven patients.

Tarantino MD, Cuker A, Hardesty B, Roberts JC, Sholzberg M.

Haemophilia. 2017 Jan;23(1):25-32. doi: 10.1111/hae.13040. Epub 2016 Aug 10.

PMID:
27511890
31.

Integrated multidisciplinary care for the management of chronic conditions in adults: an overview of reviews and an example of using indirect evidence to inform clinical practice recommendations in the field of rare diseases.

Yeung CH, Santesso N, Zeraatkar D, Wang A, Pai M, Sholzberg M, Sch√ľnemann HJ, Iorio A.

Haemophilia. 2016 Jul;22 Suppl 3:41-50. doi: 10.1111/hae.13010.

PMID:
27348400
32.

Understanding stakeholder important outcomes and perceptions of equity, acceptability and feasibility of a care model for haemophilia management in the US: a qualitative study.

Lane SJ, Sholapur NS, Yeung CH, Iorio A, Heddle NM, Sholzberg M, Pai M.

Haemophilia. 2016 Jul;22 Suppl 3:23-30. doi: 10.1111/hae.13009.

PMID:
27348398
33.

The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation.

Sholzberg M, Gomes T, Juurlink DN, Yao Z, Mamdani MM, Laupacis A.

PLoS One. 2016 Feb 25;11(2):e0149142. doi: 10.1371/journal.pone.0149142. eCollection 2016.

34.

Successful immune tolerance induction with von Willebrand factor containing concentrate in an adult with haemophilia A and chronic inhibitor - a case study.

Sholzberg M, Floros G, Teitel J.

Haemophilia. 2016 Mar;22(2):e104-e106. doi: 10.1111/hae.12871. Epub 2016 Jan 29. No abstract available.

PMID:
26822897
35.

Bleeding complications from the direct oral anticoagulants.

Sholzberg M, Pavenski K, Shehata N, Cserti-Gazdewich C, Lin Y.

BMC Hematol. 2015 Dec 24;15:18. doi: 10.1186/s12878-015-0039-z. eCollection 2015.

36.

Direct oral anticoagulants and the bleeding patient.

Wood B, Sholzberg M, Ackery A.

CMAJ. 2016 Feb 16;188(3):215. doi: 10.1503/cmaj.150604. Epub 2015 Oct 13. No abstract available.

37.

Prophylaxis in older Canadian adults with hemophilia A: lessons and more questions.

Jackson SC, Yang M, Minuk L, Sholzberg M, St-Louis J, Iorio A, Card R, Poon MC.

BMC Hematol. 2015 Feb 14;15:4. doi: 10.1186/s12878-015-0022-8. eCollection 2015.

38.

Safety and efficacy of thrombopoietin-receptor agonists in myelodysplastic syndromes: a systematic review and meta-analysis of randomized controlled trials.

Prica A, Sholzberg M, Buckstein R.

Br J Haematol. 2014 Dec;167(5):626-38. doi: 10.1111/bjh.13088. Epub 2014 Aug 26. Review.

PMID:
25155450
39.

Patterns of tertiary prophylaxis in Canadian adults with severe and moderately severe haemophilia B.

Jackson SC, Yang M, Minuk L, St-Louis J, Sholzberg M, Card R, Iorio A, Poon MC.

Haemophilia. 2014 May;20(3):e199-204. doi: 10.1111/hae.12391. Epub 2014 Mar 3.

PMID:
24589126
40.

Comparisons between novel oral anticoagulants and vitamin K antagonists in patients with CKD.

Harel Z, Sholzberg M, Shah PS, Pavenski K, Harel S, Wald R, Bell CM, Perl J.

J Am Soc Nephrol. 2014 Mar;25(3):431-42. doi: 10.1681/ASN.2013040361. Epub 2014 Jan 2. Review.

41.

Current status and future prospects for the prophylactic management of hemophilia patients with inhibitor antibodies.

Teitel JM, Sholzberg M.

Blood Rev. 2013 Mar;27(2):103-9. doi: 10.1016/j.blre.2013.02.003. Epub 2013 Feb 27. Review.

PMID:
23452718
42.

Recurrent disseminated intravascular coagulation caused by intermittent dosing of rifampin.

Havey TC, Cserti-Gazdewich C, Sholzberg M, Keystone JS, Gold WL.

Am J Trop Med Hyg. 2012 Feb;86(2):264-7. doi: 10.4269/ajtmh.2012.11-0598. Review.

Supplemental Content

Loading ...
Support Center